NO20001793D0 - Fremgangsmåte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider - Google Patents
Fremgangsmåte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptiderInfo
- Publication number
- NO20001793D0 NO20001793D0 NO20001793A NO20001793A NO20001793D0 NO 20001793 D0 NO20001793 D0 NO 20001793D0 NO 20001793 A NO20001793 A NO 20001793A NO 20001793 A NO20001793 A NO 20001793A NO 20001793 D0 NO20001793 D0 NO 20001793D0
- Authority
- NO
- Norway
- Prior art keywords
- pseudotetrapeptides
- azacycloalkylalkanoyl
- preparing
- preparing azacycloalkylalkanoyl
- azacycloalkylalkanoyl pseudotetrapeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6171997P | 1997-10-10 | 1997-10-10 | |
PCT/US1998/021326 WO1999019294A1 (en) | 1997-05-14 | 1998-10-09 | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001793D0 true NO20001793D0 (no) | 2000-04-06 |
NO20001793L NO20001793L (no) | 2000-04-06 |
Family
ID=22037674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001793A NO20001793L (no) | 1997-10-10 | 2000-04-06 | FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider |
Country Status (18)
Country | Link |
---|---|
US (1) | US6180759B1 (no) |
EP (1) | EP1030831A4 (no) |
JP (1) | JP2001519411A (no) |
KR (1) | KR20010024467A (no) |
CN (1) | CN1278791A (no) |
AP (1) | AP1057A (no) |
AU (1) | AU738114B2 (no) |
BG (1) | BG104408A (no) |
BR (1) | BR9814068A (no) |
CA (1) | CA2306823A1 (no) |
EA (1) | EA002724B1 (no) |
HU (1) | HUP0003788A3 (no) |
IL (1) | IL135553A0 (no) |
NO (1) | NO20001793L (no) |
OA (1) | OA11369A (no) |
PL (1) | PL340915A1 (no) |
SK (1) | SK4332000A3 (no) |
ZA (1) | ZA989241B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491942A (zh) * | 1996-08-21 | 2004-04-28 | ���µ�˹ҩ����Ʒ��˾ | N-[n-n-(4-(哌啶-4-基)丁酰基)-n-乙基甘氨酰基]化合物的不吸湿的稳定结晶形式 |
CN100422147C (zh) * | 2002-11-01 | 2008-10-01 | 北京天衡药物研究院 | 一种制备0-取代磺酰酪氨酸类化合物的方法 |
KR100841409B1 (ko) * | 2003-12-16 | 2008-06-25 | 에스케이케미칼주식회사 | 암로디핀 겐티세이트 염과 이의 제조방법 |
CN103254265B (zh) * | 2012-02-21 | 2016-07-13 | 上海希迈医药科技有限公司 | 醋酸阿比特龙三氟乙酸盐及其制备方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1042487A (en) * | 1964-06-25 | 1966-09-14 | Ici Ltd | Polypeptide derivatives |
JPS6322081A (ja) * | 1986-07-11 | 1988-01-29 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
IE902238A1 (en) * | 1989-06-30 | 1991-01-16 | Abbott Lab | Tetrapeptide type-b cck receptor ligands |
IE914334A1 (en) * | 1990-12-17 | 1992-06-17 | Black James Foundation | Tetrapeptide derivatives and analogues |
US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
HU222248B1 (hu) * | 1993-10-15 | 2003-05-28 | Aventis Pharmaceuticals Inc. | Trombózis elleni hatású (aza-cikloalkil)-alkanoil-peptidek, -pszeudopeptidek és ezeket a vegyületeket tartalmazó gyógyászati készítmények |
GB9516994D0 (en) * | 1995-08-18 | 1995-10-18 | Iaf Biochem Int | Solution synthesis of peripheral acting analgestic opioid tetrapeptides |
EP0768384B1 (en) * | 1995-10-11 | 2001-06-13 | Holland Sweetener Company V.o.F. | Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester |
CN1491942A (zh) * | 1996-08-21 | 2004-04-28 | ���µ�˹ҩ����Ʒ��˾ | N-[n-n-(4-(哌啶-4-基)丁酰基)-n-乙基甘氨酰基]化合物的不吸湿的稳定结晶形式 |
NL1005808C2 (nl) * | 1997-04-14 | 1998-10-19 | Dsm Nv | Hexahydro-aspartaamamiden en werkwijze voor de bereiding ervan. |
-
1998
- 1998-10-09 JP JP2000515867A patent/JP2001519411A/ja active Pending
- 1998-10-09 IL IL13555398A patent/IL135553A0/xx unknown
- 1998-10-09 HU HU0003788A patent/HUP0003788A3/hu unknown
- 1998-10-09 CN CN98810983A patent/CN1278791A/zh active Pending
- 1998-10-09 ZA ZA989241A patent/ZA989241B/xx unknown
- 1998-10-09 KR KR1020007003829A patent/KR20010024467A/ko not_active Application Discontinuation
- 1998-10-09 BR BR9814068-0A patent/BR9814068A/pt not_active IP Right Cessation
- 1998-10-09 PL PL98340915A patent/PL340915A1/xx unknown
- 1998-10-09 CA CA002306823A patent/CA2306823A1/en not_active Abandoned
- 1998-10-09 EA EA200000399A patent/EA002724B1/ru not_active IP Right Cessation
- 1998-10-09 EP EP98953345A patent/EP1030831A4/en not_active Withdrawn
- 1998-10-09 AP APAP/P/2000/001781A patent/AP1057A/en active
- 1998-10-09 SK SK433-2000A patent/SK4332000A3/sk unknown
- 1998-10-09 AU AU10746/99A patent/AU738114B2/en not_active Ceased
-
2000
- 2000-03-31 OA OA1200000096A patent/OA11369A/en unknown
- 2000-04-06 NO NO20001793A patent/NO20001793L/no not_active Application Discontinuation
- 2000-04-07 US US09/544,680 patent/US6180759B1/en not_active Expired - Fee Related
- 2000-05-08 BG BG104408A patent/BG104408A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ZA989241B (en) | 1999-06-04 |
EA002724B1 (ru) | 2002-08-29 |
OA11369A (en) | 2004-01-27 |
AU1074699A (en) | 1999-05-03 |
CA2306823A1 (en) | 1999-04-22 |
JP2001519411A (ja) | 2001-10-23 |
HUP0003788A3 (en) | 2001-05-28 |
AU738114B2 (en) | 2001-09-06 |
NO20001793L (no) | 2000-04-06 |
BR9814068A (pt) | 2000-09-26 |
BG104408A (bg) | 2000-12-29 |
SK4332000A3 (en) | 2000-12-11 |
KR20010024467A (ko) | 2001-03-26 |
EP1030831A1 (en) | 2000-08-30 |
PL340915A1 (en) | 2001-03-12 |
HUP0003788A2 (hu) | 2001-04-28 |
EA200000399A1 (ru) | 2000-10-30 |
CN1278791A (zh) | 2001-01-03 |
US6180759B1 (en) | 2001-01-30 |
AP2000001781A0 (en) | 2000-06-30 |
AP1057A (en) | 2002-04-08 |
IL135553A0 (en) | 2001-05-20 |
EP1030831A4 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO994771D0 (no) | FremgangsmÕte ved fremstilling av oligosakkarider | |
NO985064L (no) | FremgangsmÕte ved fremstilling av sildenafil | |
ATE281927T1 (de) | Giessverfahren | |
NO20013150L (no) | Fremgangsmate ved fremstilling av 5-cyanftalid | |
NO20013667L (no) | Fremgangsmate ved fremstilling av 5-cyanoftalid | |
NO991982D0 (no) | FremgangsmÕte ved hydrogenering | |
NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
NO20002319D0 (no) | FremgangsmÕte for fremstilling av fulven-metallkomplekser | |
IL134059A0 (en) | Process for preparing aminoarylacetylenes | |
NO20000355D0 (no) | Fremgangsmåte for fremstilling av cyklopropylacetylen | |
NO20003079D0 (no) | Polymerisasjon-oppstartningsprosess | |
EG23935A (en) | Process for preparing eprosartin | |
EG22077A (en) | Process for preparing 4-substituted-ih-indole-3 glyoxamides | |
NO20003080D0 (no) | Polymerisasjon-oppstartningsprosess | |
NO20001793D0 (no) | Fremgangsmåte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider | |
NO985846D0 (no) | FremgangsmÕte ved fremstilling av elementer | |
IL126184A (en) | Process for preparing pentafluoropentanol | |
NO982503D0 (no) | FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner | |
NO20001140D0 (no) | FremgangsmÕte ved fremstilling av epoksid intermediater | |
NO994749D0 (no) | FremgangsmÕte ved fremstillingen av tetraazamakrocykler | |
NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
MD810F1 (en) | Process for modified ionites obtaining | |
FI974067A0 (fi) | Process foer cellulasbehandling | |
IL125646A (en) | Process for preparing N-pyruvyl-L-proline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |